• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

First US patients receive Agili-C™ implants

Bioengineer by Bioengineer
August 16, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Louisiana State University Health Sciences Center) CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, and two LSU Health New Orleans orthopaedic surgeons announced today the successful enrollment of the first two US patients in the Agili-C IDE pivotal study. The US cases were performed by Principle Investigator Dr. Vinod Dasa, Associate Professor and Director of Orthopaedic Research, and Dr. Michael Hartman, Associate Professor of Orthopaedic Surgery at LSU Health New Orleans School of Medicine.

Share12Tweet8Share2ShareShareShare2

Related Posts

Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing

September 27, 2026

Machine Learning Meets Forensic DNA: SNPs That Identify Relatives and Separate East Asian Populations

September 27, 2026

AI-Powered Virtual Screening Uncovers Potent New Dual CDK4/6 Cancer Inhibitor

September 27, 2026

Oral Wnt-blocking pill plus lenvatinib shows promise in endometrial cancer after immunotherapy fails

September 27, 2026
Please login to join discussion

POPULAR NEWS

  • Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing

    29 shares
    Share 12 Tweet 7
  • Machine Learning Meets Forensic DNA: SNPs That Identify Relatives and Separate East Asian Populations

    29 shares
    Share 12 Tweet 7
  • AI-Powered Virtual Screening Uncovers Potent New Dual CDK4/6 Cancer Inhibitor

    29 shares
    Share 12 Tweet 7
  • Oral Wnt-blocking pill plus lenvatinib shows promise in endometrial cancer after immunotherapy fails

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing

Machine Learning Meets Forensic DNA: SNPs That Identify Relatives and Separate East Asian Populations

AI-Powered Virtual Screening Uncovers Potent New Dual CDK4/6 Cancer Inhibitor

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.